17 results on '"Rizzardini, Giuliano"'
Search Results
2. Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
Catalog
Books, media, physical & digital resources
3. Characterisation of baseline complement values in patients with chronic hepatitis B virus infection in the phase IIb B-clear study
4. Implementation of HCV screening in the 1969–1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy
5. Distribution of patients by guideline-defined disease phase and/ or grey zones in B-Clear, an international multicentre clinical trial
6. Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy
7. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
8. SAT453 - Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
9. THU393 - Distribution of patients by guideline-defined disease phase and/ or grey zones in B-Clear, an international multicentre clinical trial
10. THU236 - Implementation of HCV screening in the 1969–1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy
11. LB004B - Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study
12. THU-117-Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance
13. THU-175-Eligibility and feasibility of hepatitis C treatment in the era of direct-acting antiviral agents: Our experience in real-world practice
14. THU-180-Treatment of genotype 3 HCV infection in the large real-life “Navigatore Lombardia” multicentre cohort: Results from three different regimens
15. THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience
16. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
17. FRI401 - Impact if HBV infection in HCV/HBV coinfected patients treated with DAAs in north Italy
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.